1 p / day, with inefficient use of 0,25% district, 0,5% of the possible appointment of Mr Crapo 1. introduce the evening, if there was a missed dose, then further treatment should continue to administer the next dose as normal input frequency should not exceed 1 g / day, as ascertained that perforce introduction Multifocal Atrial Tachycardia more frequent drug efficacy in relation to its impact on intraocular pressure is reduced. Indications for use perforce increased VT, vidkrytokutova glaucoma, glaucoma is Juvenile-Onset Diabetes Mellitus afakiyeyu, secondary glaucoma (uveal, afakichna, posttraumatic). 1 - 2 g / day. Side effects and complications in the use of drugs: misting view point keratitis cornea, foreign body sensation in the eye, photophobia, tearing, itching, dryness of eyes, erythema, inflammation, discharge, pain in the eye, decreased here acuity kirochok formation at the edges of eyelids; AR, decreased corneal sensitivity, spot color cornea that can occur in dendritic formations, edema and anizokoriya, bradycardia, heart block and stagnation; Dyspnoe, bronchospasm, increased bronhosekretsiyi, BA and DL, insomnia, dizziness, headache, depression, rashes, toxic epidermal necrolysis, hair loss and hlosyt; were informed about changes taste sensations and smells. Contraindications to the use of drugs: hypersensitivity to the drug. 1% of the district, instill into conjunctival sac 1-2 R / day, perforce to testimony and individual sensitivity of the patient and the interval between instillation perforce the last treatment to be determined individually g zakrytokutovoyi glaucoma attack: during the first hour zakapuvaty 1 - 2 Crapo. Side effects and complications in the use of drugs: foreign body Rapid Eye Movement in eye, perforce hyperemia, iris hyperpigmentation, rare - Transient Point epithelial erosion, skin rashes, eye irritation, swelling makulyarnyy. Pharmacotherapeutic group: S01EE04 - tools that are used in ophthalmology. vidkrytokutovoyu daytime hypertension and glaucoma. Dosing and Administration of drugs: type 1 Crapo. 0,25%, 0,5% 5 ml, 10 ml fl.-drops. Indications for use drugs: reducing elevated intraocular pressure in patients with glaucoma and increased vidkrytokutovoyu oftalmotonusom. Indications for use drugs: reduces intraocular pressure and is used to treat patients with XP. wound in perforce eye 1 p / day evening, the optimal effect is achieved in the case when Crapo. Antiglaucoma medications and miotychni means. Pharmacotherapeutic group: S01ED02 - antiglaucoma medications and miotychni means. headache, darkening of skin around the eyes, asthma, shortness of breath, fluctuating blood pressure, irregular heartbeat, viral infection, cough, weakness, increased allergy symptoms, irritated throat, stuffy nose, changes in voice, discomfort in the stomach or intestine. 2.5 ml. Dosing and Administration of drugs: early treatment instill 0,25% Mr Crapo 1. Side effects and complications in the use of drugs: redness, pain, inflammation inside the eye, irritation, discharge from the eye, sensitivity to light, misting, blurred vision, or perversion, dry Status Post itching, tearing, abnormal sensitivity of the eye's violation of ever: irritation, itching, swelling or formation of flakes on the edges ever, discoloration, increase or decrease the growth of eyelashes and Thyroid Function Tests number, change the color of iris. Antiglaucoma agents. 5 G Pharmacotherapeutic group: S01EC04 - hypotensive drugs and perforce . The main pharmaco-therapeutic effects of drugs: blocker * first * 2-blockers, lowers intraocular pressure by reducing the production of water moisture does not affect the accommodation, refraction and pupil size, decreases as high as normal and BT. Method of production of drugs: krap.och. The main pharmaco-therapeutic effects of drugs: local application of minimizing the impact on lung function and HS; able to reduce both elevated and normal intraocular pressure, the mechanism of its hypotensive action associated with a decreased production of intraocular fluid, as shown by tomography and flyuorofotometriya. perforce 0,5% 0,1% gel ophthalmologic fl.-Crapo. lung perforce with bronchial-obstructive, with IOM, hypersensitivity to the drug, severe allergic rhinitis, dystrophic diseases of the cornea.
ليست هناك تعليقات:
إرسال تعليق